A major international study shows that increasing a naturally occurring molecule can help restore memory in animal models of ...
PM EST TAMPA, Fla. and LONDON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology ...
Company expands its ADC pipeline and patent estate for novel, differentiated ADCs New pipeline candidate AKTX-102 leverages ...
Morning Overview on MSN
Deadly brain cancer with no cure may finally have a kill switch
Glioblastoma is the diagnosis that neuro-oncologists dread and patients fear, a fast-growing brain cancer that resists ...
AlphaGenome is a DNA sequence model that advances regulatory variant-effect prediction to understand genome function.
Skyhawk Therapeutics announces interim results in patients from phase 1 clinical trial as a treatment for Huntington’s disease: Waltham, Massachusetts Thursday, January 29, 2026 ...
10don MSN
AlphaGenome: Google’s new AI tool that can decipher and predict DNA changes. How does it work?
A new AI model by Google DeepMind can decipher DNA and predict mutations, opening new doors for disease research. View on ...
The tool helps scientists understand how single-letter mutations and distant DNA regions influence gene activity, shaping ...
By targeting proteins used to splice genes, UC San Diego researchers have unlocked a new approach to treating triple-negative ...
The history of genomics has long been a story of reading a book where only every fiftieth page made sense. While the Human Genome Project gave us the full sequence of human DNA over two decades ago, w ...
Treatment with SKY-0515 results in dose-dependent reductions of mHTT protein in blood of 62% at the 9mg dose, and ...
Treatment with SKY-0515 results in dose-dependent reductions of mHTT protein in blood of 62% at the 9mg dose, and dose-dependent PMS1 mRNA reduction of 26%. PMS1 is a key driver of somatic CAG repeat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results